60 Recruiting Solid Tumor Phase 1 Clinical Trials
Active phase 1 studies for solid tumor enrolling across the USA. Verify eligibility and contact site coordinators.
All Solid Tumor studiesPhase 1 Studies for Solid Tumor
A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid Tumors
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer
📍 Memorial Sloan Kettering Monmouth (All Protocol Activities) — Middletown, New Jersey
View Study & Checklist ➔A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activites) — Basking Ridge, New Jersey
View Study & Checklist ➔Study of PD1 Blockade by Pembrolizumab With Stereotactic Body Radiotherapy in Advanced Solid Tumors
📍 University of Chicago — Chicago, Illinois
View Study & Checklist ➔A Study Evaluating DS-1055a in Participants With Relapsed or Refractory Locally Advanced or Metastatic Solid Tumors
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Concurrent Azeliragon With Craniospinal Irradiation
📍 NYU Langone Health — New York, New York
View Study & Checklist ➔A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
📍 HonorHealth Research Institute — Scottsdale, Arizona
View Study & Checklist ➔Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion
📍 Honor Health Research Institute — Scottsdale, Arizona
View Study & Checklist ➔Dose-Escalation Study of E7727, an Oral Cytidine Deaminase Inhibitor With Oral Decitabine in Subjects With Solid Tumors
📍 USC Norris Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies
📍 Stanford Cancer Institute — Palo Alto, California
View Study & Checklist ➔A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors
📍 City of Hope — Duarte, California
View Study & Checklist ➔Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
📍 Phoenix Children'S Hospital — Phoenix, Arizona
View Study & Checklist ➔Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors
📍 Mayo Clinic — Rochester, Minnesota
View Study & Checklist ➔Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors
📍 University of Texas MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔TH1902 in Patients With Advanced Solid Tumors
📍 Karmanos Cancer Institute — Detroit, Michigan
View Study & Checklist ➔A Study of NDI 1150-101 in Patients With Solid Tumors
📍 Honor Health Research Institute — Scottsdale, Arizona
View Study & Checklist ➔A Study of LY3200882 in Participants With Solid Tumors
📍 University of Louisville — Louisville, Kentucky
View Study & Checklist ➔Study of GS-4528 in Adults With Solid Tumors
📍 The University of Washington/FHCC — Seattle, Washington
View Study & Checklist ➔Study of PYX-106 in Solid Tumors
📍 HonorHealth Research Institute — Scottsdale, Arizona
View Study & Checklist ➔Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies
📍 LSU Health Sciences Center - Shreveport — Shreveport, Louisiana
View Study & Checklist ➔A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK121-NX in Patients With Advanced Solid Tumors
📍 UC San Diego Moores Cancer Center — La Jolla, California
View Study & Checklist ➔A Phase 1 Study of BHV-1530 in Advanced Solid Tumors
📍 Site-111 — Newport Beach, California
View Study & Checklist ➔Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
📍 Hackensack University Medical Center PARTNER — Hackensack, New Jersey
View Study & Checklist ➔A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
📍 University of Arkansas Medical School — Little Rock, Arkansas
View Study & Checklist ➔A Study to Evaluate the Safety and Antitumor Activity of GS-1206 in Adults With Solid Tumors
📍 NEXT Oncology Dallas — Austin, Texas
View Study & Checklist ➔A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
📍 Site 0264 — Aurora, Colorado
View Study & Checklist ➔FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
📍 Georgetown Lombardi Comprehensive Cancer Center — Washington D.C., District of Columbia
View Study & Checklist ➔A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔PET [89Zr]DFO-starPEG in Solid Tumors
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
📍 Stern Center for Cancer Clinical Trials and Research — Orange, California
View Study & Checklist ➔Trial of DFP-14927 in Advanced Solid Tumors
📍 UCLA Department of Medicine- Hematology/Oncology — Los Angeles, California
View Study & Checklist ➔Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence
📍 Miller Children's and Women's Hospital Long Beach — Long Beach, California
View Study & Checklist ➔A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid Tumors
📍 Mary Crowley Cancer Research — Dallas, Texas
View Study & Checklist ➔A Study of ASP3082 in Adults With Advanced Solid Tumors
📍 City of Hope National Medical Center — Duarte, California
View Study & Checklist ➔Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors
📍 NEXT Oncology — San Antonio, Texas
View Study & Checklist ➔A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
📍 ACRC/Arizona Clinical Research Center, Inc — Tucson, Arizona
View Study & Checklist ➔A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
📍 UCLA Santa Monica Hematology Oncology — Santa Monica, California
View Study & Checklist ➔A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors
📍 START Los Angeles — Los Angeles, California
View Study & Checklist ➔FIH Study to Evaluate Safety, Tolerability, PK, PD & Preliminary Efficacy of AT03-65 With Advanced Solid Tumors
📍 Oregon Health & Science University (OHSU) — Portland, Oregon
View Study & Checklist ➔A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
📍 University of Pennsylvania Perelman Center for Advanced Medicine — Philadelphia, Pennsylvania
View Study & Checklist ➔A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
📍 UAB Comprehensive Cancer Center — Birmingham, Alabama
View Study & Checklist ➔STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers
📍 Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors
📍 University of Texas Health Science Center at San Antonio — San Antonio, Texas
View Study & Checklist ➔A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors
📍 UC San Diego Moores Cancer Center — La Jolla, California
View Study & Checklist ➔A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors
📍 Exelixis Clinical Site #5 — San Francisco, California
View Study & Checklist ➔NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors
📍 Georgetown Lombardi Comprehensive Cancer Center — Washington D.C., District of Columbia
View Study & Checklist ➔Phase I Study VG2025 as a Single Agent and in Combination Therapy With Nivolumab in Subjects With Advanced Malignant Solid Tumors
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors
📍 Children's National Hospital — Washington D.C., District of Columbia
View Study & Checklist ➔A Study of PYX-201 in Advanced Solid Tumors
📍 HonorHealth Research Institute — Scottsdale, Arizona
View Study & Checklist ➔A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
📍 Site-113 — Duarte, California
View Study & Checklist ➔Study of STP938 (Dencatistat) in Advanced Solid Tumours
📍 Comprehensive Hematology Oncology, LLC — St. Petersburg, Florida
View Study & Checklist ➔Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors
📍 Gabrail Cancer Center — Canton, Ohio
View Study & Checklist ➔Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors
📍 Lurie Children's Hospital — Chicago, Illinois
View Study & Checklist ➔Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors
📍 CBCC Global Research Site 001 — Scottsdale, Arizona
View Study & Checklist ➔Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
📍 Start Lacn — Los Angeles, California
View Study & Checklist ➔A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
📍 Christiana Care Health System - Newark- Site Number : 8400011 — Newark, Delaware
View Study & Checklist ➔5-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory Tumors
📍 University of Iowa Health Care — Iowa City, Iowa
View Study & Checklist ➔